AI-generated summary
This review describes the range of cutaneous vascular lesions dermatologists encounter and the treatments currently used, including steroids, laser therapy, surgery and endovascular therapy. The authors report that each method has limitations such as recurrence, comorbidities, toxicity or lesion location. They describe photodynamic therapy, antiangiogenic therapy and newer sclerotherapy methods as promising developments that may address some of these limitations.
- Who or what was studied
- Patients with cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous and venous malformations, Kaposi sarcomas, angiosarcomas and angiofibromas
- Limits stated in the abstract
- The abstract describes the promising therapies only in general terms and does not report study numbers, outcomes or certainty of evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scmsjournal.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.